Ifp Advisors, Inc Moderna, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 910 shares of MRNA stock, worth $36,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares

910

Previous 328 177.44%

Holding current value

$36,026

Previous $34,000 217.65%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$101.21 - $166.61 $58,904 - $96,967	582 Added 177.44%	910 $108,000
Q1 2024 Jul 30, 2024	SELL	$85.37 - $115.44 $18,610 - $25,165	-218 Reduced 39.93%	328 $34,000
Q4 2023 Jan 09, 2024	SELL	$69.51 - $104.43 $20,018 - $30,075	-288 Reduced 34.53%	546 $54,000
Q3 2023 Oct 12, 2023	BUY	$96.41 - $126.61 $12,726 - $16,712	132 Added 18.8%	834 $86,000
Q2 2023 Aug 04, 2023	SELL	$118.5 - $160.53 $10,665 - $14,447	-90 Reduced 11.36%	702 $85,000
Q1 2023 Apr 18, 2023	SELL	$135.66 - $197.02 $140,950 - $204,703	-1,039 Reduced 56.74%	792 $121,000
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $176,149 - $312,539	-1,488 Reduced 44.83%	1,831 $78,000
Q3 2022 Nov 08, 2022	SELL	$118.07 - $194.18 $36,247 - $59,613	-307 Reduced 8.47%	3,319 $144,000
Q2 2022 Sep 06, 2022	BUY	$117.13 - $176.59 $424,713 - $640,315	3,626 New	3,626 $124,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $424,713 - $640,315	-3,626 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$126.46 - $235.05 $304,642 - $566,235	2,409 Added 197.95%	3,626 $624,000
Q1 2022 Aug 08, 2022	BUY	$126.46 - $235.05 $28,706 - $53,356	227 Added 22.93%	1,217 $209,000
Q4 2021 Jan 12, 2022	SELL	$225.82 - $368.51 $3.19 Million - $5.2 Million	-14,118 Reduced 93.45%	990 $255,000
Q3 2021 Oct 06, 2021	BUY	$221.9 - $484.47 $3.09 Million - $6.75 Million	13,925 Added 1177.09%	15,108 $5.81 Million
Q2 2021 Jul 13, 2021	BUY	$129.91 - $234.98 $34,945 - $63,209	269 Added 29.43%	1,183 $276,000
Q1 2021 Apr 30, 2021	SELL	$109.18 - $185.98 $133,745 - $227,825	-1,225 Reduced 57.27%	914 $118,000
Q4 2020 Jan 25, 2021	SELL	$65.74 - $169.86 $1,709 - $4,416	-26 Reduced 1.2%	2,139 $224,000
Q3 2020 Oct 29, 2020	BUY	$54.34 - $94.85 $41,135 - $71,801	757 Added 53.76%	2,165 $150,000
Q2 2020 Aug 05, 2020	SELL	$29.67 - $80.0 $36,375 - $98,080	-1,226 Reduced 46.55%	1,408 $86,000
Q1 2020 May 12, 2020	BUY	$17.78 - $31.58 $4,160 - $7,389	234 Added 9.75%	2,634 $74,000
Q4 2019 Jan 17, 2020	BUY	$13.93 - $21.28 $11,144 - $17,024	800 Added 50.0%	2,400 $47,000
Q3 2019 Nov 07, 2019	BUY	$12.26 - $18.07 $19,616 - $28,912	1,600 New	1,600 $25,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account